A
54.04
0.13 (0.24%)
| Previous Close | 53.91 |
| Open | 53.95 |
| Volume | 1,110,082 |
| Avg. Volume (3M) | 2,089,375 |
| Market Cap | 4,332,107,264 |
| Price / Book | 3.62 |
| 52 Weeks Range | |
| Earnings Date | 10 Nov 2025 |
| Diluted EPS (TTM) | -3.75 |
| Total Debt/Equity (MRQ) | 3.34% |
| Current Ratio (MRQ) | 16.80 |
| Operating Cash Flow (TTM) | -262.63 M |
| Levered Free Cash Flow (TTM) | -177.47 M |
| Return on Assets (TTM) | -18.52% |
| Return on Equity (TTM) | -27.92% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Akero Therapeutics, Inc. | Bearish | Bearish |
AIStockmoo Score
-0.6
| Analyst Consensus | -3.5 |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 4.0 |
| Average | -0.63 |
|
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 1.37% |
| % Held by Institutions | 109.31% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 56.00 (Jefferies, 3.63%) | Hold |
| Median | 54.00 (-0.07%) | |
| Low | 54.00 (HC Wainwright & Co., -0.07%) | Hold |
| 54.00 (Canaccord Genuity, -0.07%) | Hold | |
| Average | 54.67 (1.17%) | |
| Total | 3 Hold | |
| Avg. Price @ Call | 54.01 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 10 Oct 2025 | 54.00 (-0.07%) | Hold | 53.88 |
| 04 Sep 2025 | 72.00 (33.23%) | Buy | 44.03 | |
| Canaccord Genuity | 09 Oct 2025 | 54.00 (-0.07%) | Hold | 54.08 |
| Jefferies | 09 Oct 2025 | 56.00 (3.63%) | Hold | 54.08 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |